Risk of anaphylactic reaction associated with glatiramer acetate, used to treat multiple sclerosis
Critical priority
What you should do
- 1If you experience anaphylactic reaction symptoms, stop taking glatiramer acetate and seek immediate medical help by calling 9-1-1.
- 2Do not restart taking glatiramer acetate if you have experienced anaphylaxis unless your healthcare provider has identified another clear cause for the anaphylaxis.
- 3Report any health product-related side effects to Health Canada.
- 4What healthcare professionals should doInform patients and/or caregivers of the signs and symptoms of anaphylactic reactions, which may overlap with those of an immediate post-injection reaction.
- 5Instruct patients to seek immediate emergency medical care in the event of an anaphylactic reaction.
The issue
Product safety - New safety information
Affected product
Glatiramer acetate
Where it was sold
Canada (national)Reported in the official notice — confirm there.
Issued by
Health Canada
Read the official Government of Canada notice
All recallsRecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.